Clinical Trials in North Carolina

Showing 6901-6920 of 20,428 trials

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05136898

This study aims to demonstrate that home instillation of UGN-102 is a feasible alternative to instillation in a clinical setting, which might mitigate patient challenges (logistical, expense, and comfort) when receiving treatment for low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder

UroGen Pharma Ltd.8 participantsStarted Nov 2021

Homewood, Alabama, United States • Indianapolis, Indiana, United States • Greensboro, North Carolina, United States +2 more locations

COMPLETEDNA41 miles

Cereset Research In Healthcare Workers During COVID-19

NCT04682197

The purpose of this study is to evaluate the use of Cereset Research to improve the symptoms of stress in healthcare workers in an open label, waitlist controlled pilot clinical trial, during the period of COVID-19.

Health PersonnelStressAnxiety+4 more

Wake Forest University Health Sciences144 participantsStarted Dec 2021

Winston-Salem, North Carolina, United States

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Cereset Research In Healthcare Workers During COVID-19

Find Trials by Condition in North Carolina

(YMP) Young Moms Program

Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients

Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

A Safety and Efficacy Study in Patients With Gastric Cancer

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency

Pilot Trial of the RUBI Program for Autistic Adults

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)

A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release

Acupuncture for Preterm Infants Requiring Eye-exam